URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)
URBAN ARCH (5/5) 波士顿队列 - 酒精和 HIV 相关合并症和并发症:虚弱、功能障碍、跌倒和骨折(4F 研究)
基本信息
- 批准号:10165944
- 负责人:
- 金额:$ 16.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-20 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAIDS/HIV problemAcquired Immunodeficiency SyndromeAcuteAddressAffectAlcohol consumptionAlcohol or Other Drugs useAlcoholsAnti-Retroviral AgentsAreaAwardBostonCOVID-19COVID-19 pandemicCessation of lifeCollaborationsCoronavirusCountyDataData AnalysesDiseaseDisease ProgressionDrug Use DisorderDrug usageEmergency SituationEmploymentEpidemicEventExposure toFire - disastersFoodFractureFundingGoalsHIVHIV InfectionsHIV SeropositivityHIV antiretroviralHandwashingHealthHealth Services AccessibilityHealth systemHealthcare SystemsHeavy DrinkingHomelessnessHygieneIllicit DrugsIncidenceInfectionInfrastructureInterventionInterviewLeadLonelinessMassachusettsMental DepressionMental HealthMissionNational Institute on Alcohol Abuse and AlcoholismNatural DisastersOutcomePain interferenceParentsParticipantPharmaceutical PreparationsPopulationPrevalencePreventive careProspective StudiesProspective cohortPublic HealthResearchResearch PriorityRiskRussiaSeveritiesShelter facilitySocial DistanceSocial isolationSocial supportStressSubstance Use DisorderSurveysSymptomsTimeTranslational ResearchUgandaUncertaintyUnemploymentUnited States National Institutes of Healthaddictionalcohol and other drugalcohol researchalcohol use disorderco-infectioncohortcomorbiditycoronavirus diseasedepressive symptomsdesignfallsfood insecurityfrailtyfunctional disabilityhealth care availabilityhigh riskinfection ratemedication compliancemedication nonadherencemembernovelnovel coronavirusopioid mortalitypandemic diseaseparent grantpreventprospectivesafety netstressor
项目摘要
This proposal is an urgent competitive revision designed to supplement an existing NIH-funded study to assess
the impact of the COVID-19 pandemic on alcohol and other drug use, and medication adherence that is critical
for preventing HIV disease progression, among people living with HIV (PLWH). The COVID-19 pandemic has
profoundly affected lives around the world. In addition to the effects of infection itself, to which PLWH may be
more susceptible, COVID-19 has affected employment, access to healthcare, and very likely, the incidence
and consequences of other health conditions, by limiting access to healthcare, and through the implementation
of physical (social) distancing. PLWH may be at higher risk of consequences of social isolation, and those with
addiction, unemployment and homelessness are at an even higher risk with restrictions that affect food
availability, hygiene (e.g. handwashing), shelter, and other traditional supports now absent from the already
fragile societal safety net.
The over-arching goal of this proposal is to assess the impact of the COVID-19 pandemic and the effects of
physical (social) distancing and other mitigation strategies (collectively termed “pandemic exposure”) on
substance use (heavy alcohol use and/or other drug use including nonmedical prescription medication use)
and HIV medication adherence among PLWH.
Among an ongoing, well-characterized cohort of people living with HIV/AIDS (the existing Boston ARCH
Cohort parent study), this project will:
Aim 1: Determine prospective associations between pandemic exposure and changes in alcohol (and other
drug) use (primarily) and HIV antiretroviral (ARV) medication nonadherence (secondarily).
Aim 2: Identify associations between pandemic exposure and secondary stressors, specifically, food
insecurity, loneliness, and pain interference (with activities); and associations between those stressors and
changes in alcohol (and other drug) use and HIV ARV medication nonadherence.
Aim 3: Determine who is most affected by the pandemic by examining moderators of the associations between
pandemic exposure and changes in substance use and HIV ARV nonadherence.
To achieve these aims, a supplemental COVID-19 specific assessment will be administered to participants
at two time points (6 months apart). Baseline data on substance use, depression, and frailty, collected during
pre-pandemic assessments as part of the parent study will be compared against data collected via
supplemental COVID-specific assessments. Achieving this proposal’s aims is an important step to identifying
modifiable targets for interventions to prevent increased substance use and HIV disease progression after an
extreme event such as COVID-19.
该建议是一项紧急竞争性修订,旨在补充现有的NIH资助研究以评估
COVID-19大流行对酒精和其他药物使用的影响以及至关重要的药物依从性
在艾滋病毒(PLWH)中预防艾滋病毒疾病进展。 COVID-19大流行有
深远影响了世界各地的生活。除了感染本身的影响外,PLWH可能是
Covid-19更容易受到影响,影响了就业,获得医疗保健,并且很可能是事件
以及其他健康状况的后果,通过限制获得医疗保健和实施
物理(社会)距离。 PLWH可能面临社会隔离后果的风险更高,与
成瘾,失业和无家可归的风险更高,受到影响食物的限制
可用性,卫生(例如洗手),庇护所和其他传统支持现在已经存在
脆弱的社会安全网。
该提案的整理目标是评估19009年大流行的影响以及
物理(社交)距离和其他缓解策略(统称为“大流行暴露”)
药物使用(大量饮酒和/或其他药物使用,包括非医学处方药)
PLWH中的HIV药物依从性。
在持续的,充分表现的艾滋病毒/艾滋病的人群中(现有的波士顿拱门
同类父母研究),该项目将:
目标1:确定大流行暴露与酒精变化之间的前瞻性关联(以及其他
药物使用(主要是)和HIV抗逆转录病毒(ARV)药物不遵守(次要)。
目标2:确定大流行暴露与次应力源之间的关联,特别是食物
不安全感,孤独和疼痛干扰(活动);以及这些压力源与
酒精(和其他药物)使用和HIV ARV药物不遵守的变化。
目标3:通过检查主持人的关联之间的主持人,确定谁受到大流行的影响
大流行的暴露以及药物使用和HIV ARV不遵守的变化。
为了实现这些目标,将对参与者进行补充COVID-19的特定评估
在两个时间点(相距6个月)。有关物质使用,抑郁和脆弱的基线数据,在
作为父母研究的一部分,大流行评估将与通过
补充共价特异性评估。实现这一建议的目标是确定的重要步骤
可修改的靶标,以防止在
极端事件,例如Covid-19。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy C. Heeren其他文献
Factors associated with initiation of primary medical care for HIV-infected persons.
与艾滋病毒感染者开始初级医疗保健相关的因素。
- DOI:
10.1016/0002-9343(94)90301-8 - 发表时间:
1994 - 期刊:
- 影响因子:0
- 作者:
J. Samet;M. J. Retondo;M. J. Retondo;K. Freedberg;M. Stein;Timothy C. Heeren;H. Libman - 通讯作者:
H. Libman
Multiple comparisons in over-the-counter drug clinical trials with both positive and placebo controls.
非处方药临床试验中与阳性对照和安慰剂对照的多重比较。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:2
- 作者:
R. D’Agostino;Timothy C. Heeren - 通讯作者:
Timothy C. Heeren
Alcohol Policies and Motor Vehicle Injury Fatalities Among Underage Youth in the United States
- DOI:
10.1016/j.jadohealth.2015.10.042 - 发表时间:
2016-02-01 - 期刊:
- 影响因子:
- 作者:
Scott Evan Hadland;Ziming Xuan;Jason Blachette;Vishnudas Sarda;Monica H. Swahn;Timothy C. Heeren;Timothy S. Naimi - 通讯作者:
Timothy S. Naimi
Consensus on synergism between cigarette smoke and other environmental carcinogens in the causation of lung cancer.
香烟烟雾与其他环境致癌物在导致肺癌方面的协同作用达成共识。
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:0
- 作者:
Arnold E. Reif;Timothy C. Heeren - 通讯作者:
Timothy C. Heeren
Adenocarcinoma and Barrett's esophagus. An overrated risk?
腺癌和巴雷特食管。
- DOI:
10.1016/0016-5085(84)90090-8 - 发表时间:
1984 - 期刊:
- 影响因子:29.4
- 作者:
S. Spechler;S. Spechler;A. Robbins;A. Robbins;H. Rubins;H. Rubins;M. Vincent;M. Vincent;Timothy C. Heeren;Timothy Heeren;W. Doos;W. Doos;T. Colton;T. Colton;E. Schimmel;E. Schimmel - 通讯作者:
E. Schimmel
Timothy C. Heeren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy C. Heeren', 18)}}的其他基金
URBAN ARCH (5/5) Boston Cohort - Alcohol and HIV-associated comorbidity and complications: Frailty, Functional impairment, Falls, and Fractures (the 4F study)
URBAN ARCH (5/5) 波士顿队列 - 酒精和 HIV 相关合并症和并发症:虚弱、功能障碍、跌倒和骨折(4F 研究)
- 批准号:
10425888 - 财政年份:2011
- 资助金额:
$ 16.36万 - 项目类别:
相似海外基金
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 16.36万 - 项目类别:
Effects of SARS-CoV-2 Antiviral Ribonucleoside Analogues on Mitochondrial DNA
SARS-CoV-2 抗病毒核糖核苷类似物对线粒体 DNA 的影响
- 批准号:
10448062 - 财政年份:2022
- 资助金额:
$ 16.36万 - 项目类别:
The 24th International AIDS Conference (AIDS 2022), 29 July-2 August 2022, Montreal, Canada and virtually
第 24 届国际艾滋病大会 (AIDS 2022),2022 年 7 月 29 日至 8 月 2 日,加拿大蒙特利尔
- 批准号:
10481133 - 财政年份:2022
- 资助金额:
$ 16.36万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10452676 - 财政年份:2021
- 资助金额:
$ 16.36万 - 项目类别:
Mechanistic Studies of Gut Dysfunction Exacerbation due to SARS-CoV-2 in HIV/SIV infected Individuals
HIV/SIV 感染者中 SARS-CoV-2 导致肠道功能恶化的机制研究
- 批准号:
10319695 - 财政年份:2021
- 资助金额:
$ 16.36万 - 项目类别: